Syros Pharmaceuticals (SYRS) – Hot Corp. News
-
Global Blood Therapeutics (GBT) and Syros Partner (SYRS) to Discover, Develop and Commercialize Novel Therapies for SCD and Beta Thalassemia
-
Syros Pharmaceuticals (SYRS) Reports Initial Clinical Data from Ongoing Phase 2 Trial of SY-1425 Showing Biological and Clinical Activity as Single Agent in Genomically Defined AML & MDS Patients
-
-
-
-
-
-
-
Back to SYRS Stock Lookup